Max van Min
Impact in
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in ⓘ
-
- CRISPR and Genetic Engineering 3
- Advanced biosensing and bioanalysis techniques 1
- RNA and protein synthesis mechanisms 1
- Genomics and Phylogenetic Studies 1
- Genomics and Chromatin Dynamics 1
- Genetics 3
- Animal Genetics and Reproduction 2
- Co-authors
- Erik Splinter (7 shared papers)Robert E. Braun (1 shared paper)Stephen A. Murray (1 shared paper)Cathleen Lutz (1 shared paper)Laura G. Reinholdt (1 shared paper)Hao He (1 shared paper)Leslie O. Goodwin (1 shared paper)Juliet Ndukum (1 shared paper)
- Journals
- Genome Research (1 paper)Frontiers in Oncology (1 paper)Nucleic Acids Research (1 paper)Clinical Chemistry (1 paper)Biotechnology Journal (1 paper)
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
Max van Min
7 papers receiving 215 citations
Peers
Comparison fields: 5 of 50
- Neurology 27
- Aging 5
- Biological Psychiatry 7
- Genetics 66
- Molecular Biology 152
Countries citing papers authored by Max van Min
This map shows the geographic impact of Max van Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max van Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max van Min more than expected).
Fields of papers citing papers by Max van Min
This network shows the impact of papers produced by Max van Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max van Min. The network helps show where Max van Min may publish in the future.
Co-authors
The 25 scholars most cited alongside Max van Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 128 | |
| 2 | 2016 | 39 | |
| 3 | 2016 | 29 | |
| 4 | 2019 | 12 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2018 | 2 |
About Max van Min
Max van Min is a scholar working on Molecular Biology, Genetics, Cancer Research, Neurology and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 217 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), Animal Genetics and Reproduction (2 papers), Cancer Genomics and Diagnostics (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), RNA and protein synthesis mechanisms (1 paper), Genomics and Phylogenetic Studies (1 paper), Acute Myeloid Leukemia Research (1 paper) and Genomics and Chromatin Dynamics (1 paper). The work is most often cited by research in Neurology (27 citations), Aging (5 citations), Biological Psychiatry (7 citations), Genetics (66 citations) and Molecular Biology (152 citations). Max van Min has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Erik Splinter, Robert E. Braun, Stephen A. Murray, Cathleen Lutz, Laura G. Reinholdt, Hao He, Leslie O. Goodwin, Juliet Ndukum, Michael Sasner and Karen L. Svenson. Their work appears in journals such as Genome Research, Frontiers in Oncology, Nucleic Acids Research, Clinical Chemistry and Biotechnology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.